78 related articles for article (PubMed ID: 16730863)
1. Unaltered susceptibility to scrapie in serotonin transporter deficient mice.
Mössner R; Yun SW; Lesch KP; Gerlach M; Klein MA; Riederer P
Neurochem Int; 2006 Oct; 49(5):454-8. PubMed ID: 16730863
[TBL] [Abstract][Full Text] [Related]
2. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
3. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 expression is correlated with abnormal prion protein accumulation in murine scrapie.
Jin JK; Na YJ; Song JH; Joo HG; Kim S; Kim JI; Choi EK; Carp RI; Kim YS; Shin T
Neurosci Lett; 2007 Jun; 420(2):138-43. PubMed ID: 17531384
[TBL] [Abstract][Full Text] [Related]
5. Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice.
Tal Y; Souan L; Cohen IR; Meiner Z; Taraboulos A; Mor F
J Neurosci Res; 2003 Jan; 71(2):286-90. PubMed ID: 12503092
[TBL] [Abstract][Full Text] [Related]
6. Early dysfunction of central 5-HT system in a murine model of bovine spongiform encephalopathy.
Vidal C; Herzog C; Haeberle AM; Bombarde C; Miquel MC; Carimalo J; Launay JM; Mouillet-Richard S; Lasmézas C; Dormont D; Kellermann O; Bailly Y
Neuroscience; 2009 Jun; 160(4):731-43. PubMed ID: 19285121
[TBL] [Abstract][Full Text] [Related]
7. Reduced thermal hyperalgesia and enhanced peripheral nerve injury after hind paw inflammation in mice lacking the serotonin-transporter.
Palm F; Mössner R; Chen Y; He L; Gerlach M; Bischofs S; Riederer P; Lesch KP; Sommer C
Eur J Pain; 2008 Aug; 12(6):790-7. PubMed ID: 18187350
[TBL] [Abstract][Full Text] [Related]
8. Unchanged scrapie pathology in brain tissue of tyrosine kinase Fyn-deficient mice.
Schwarz A; Burwinkel M; Riemer C; Schultz J; Baier M
Neurodegener Dis; 2004; 1(6):266-8. PubMed ID: 16908977
[TBL] [Abstract][Full Text] [Related]
9. Female, but not male, serotonin reuptake transporter (5-HTT) knockout mice exhibit bladder instability.
Cornelissen LL; Brooks DP; Wibberley A
Auton Neurosci; 2005 Oct; 122(1-2):107-10. PubMed ID: 16023897
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
Iwamaru Y; Shimizu Y; Imamura M; Murayama Y; Endo R; Tagawa Y; Ushiki-Kaku Y; Takenouchi T; Kitani H; Mohri S; Yokoyama T; Okada H
J Neurochem; 2008 Nov; 107(3):636-46. PubMed ID: 18717818
[TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease.
Asuni AA; Hilton K; Siskova Z; Lunnon K; Reynolds R; Perry VH; O'Connor V
Neuroscience; 2010 Feb; 165(3):662-74. PubMed ID: 19879926
[TBL] [Abstract][Full Text] [Related]
12. The effect of Fenton reaction on protease-resistant prion protein (PrPSc) degradation and scrapie infectivity.
Park SJ; Kim NH; Jeong BH; Jin JK; Choi JK; Park YJ; Kim JI; Carp RI; Kim YS
Brain Res; 2008 Oct; 1238():172-80. PubMed ID: 18771660
[TBL] [Abstract][Full Text] [Related]
13. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
Thackray AM; Hopkins L; Bujdoso R
Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
[TBL] [Abstract][Full Text] [Related]
14. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
15. Role of copper and manganese in prion disease progression.
Mitteregger G; Korte S; Shakarami M; Herms J; Kretzschmar HA
Brain Res; 2009 Oct; 1292():155-64. PubMed ID: 19635464
[TBL] [Abstract][Full Text] [Related]
16. Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein gene in neurons only.
Crozet C; Lezmi S; Flamant F; Samarut J; Baron T; Bencsik A
J Infect Dis; 2007 Apr; 195(7):997-1006. PubMed ID: 17330790
[TBL] [Abstract][Full Text] [Related]
17. Quantitative trait loci affecting prion incubation time in mice.
Stephenson DA; Chiotti K; Ebeling C; Groth D; DeArmond SJ; Prusiner SB; Carlson GA
Genomics; 2000 Oct; 69(1):47-53. PubMed ID: 11013074
[TBL] [Abstract][Full Text] [Related]
18. Social status and day-to-day behaviour of male serotonin transporter knockout mice.
Lewejohann L; Kloke V; Heiming RS; Jansen F; Kaiser S; Schmitt A; Lesch KP; Sachser N
Behav Brain Res; 2010 Aug; 211(2):220-8. PubMed ID: 20347882
[TBL] [Abstract][Full Text] [Related]
19. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
[TBL] [Abstract][Full Text] [Related]
20. Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases.
Zuber C; Knackmuss S; Rey C; Reusch U; Röttgen P; Fröhlich T; Arnold GJ; Pace C; Mitteregger G; Kretzschmar HA; Little M; Weiss S
Mol Immunol; 2008 Jan; 45(1):144-51. PubMed ID: 17576014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
